Overview
- Editors:
-
-
Alan J. Gelenberg
-
University of Arizona Health Sciences Center, Tucson, USA
-
Ellen L. Bassuk
-
The Better Homes Foundation, Newton Centre, USA
Harvard Medical School, Boston, USA
-
Stephen C. Schoonover
-
Schoonover Associates, Newton Centre, USA
Access this book
Other ways to access
Table of contents (14 chapters)
-
Front Matter
Pages i-xxxi
-
State of the Art
-
-
- Stephen C. Schoonover, Alan J. Gelenberg
Pages 3-19
-
Major Psychiatric Disorders
-
-
- Alan J. Gelenberg, Stephen C. Schoonover
Pages 23-89
-
- Alan J. Gelenberg, Stephen C. Schoonover
Pages 91-123
-
-
- Jerrold F. Rosenbaum, Alan J. Gelenberg
Pages 179-218
-
- Jeffrey B. Weilburg, Alan J. Gelenberg
Pages 219-240
-
Psychoactive Substance Abuse
-
Front Matter
Pages 241-241
-
- Steven M. Mirin, Roger D. Weiss, Shelly F. Greenfield
Pages 243-316
-
Special Topics
-
Front Matter
Pages 317-317
-
-
- Joseph Biederman, Ronald Steingard
Pages 341-388
-
- Lee S. Cohen, Jerrold F. Rosenbaum, Vicki L. Heller
Pages 389-405
-
- Jeffrey B. Weilburg, George B. Murray
Pages 407-438
-
- Andrew W. Brotman, David B. Herzog
Pages 439-455
-
-
-
Back Matter
Pages 487-504
About this book
In the eight years since the publication of the second edition of this Guide, psycho phannacotherapy has made many advances not only through the discovery of new medications but by the effective directing of their use to an ever-increasing variety of clinical disorders. These welcome developments are reflected in the concurrent growth and development of the Guide itself, which now enters adulthood with renewed vigor. Under the thoughtful and scholarly leadership of Dr. Alan Gelenberg, the third edition has undergone a significant transformation designed to meet the needs of the modem clinician. The panel of contributors is nearly double that of the former edition with the addition of nine new authors, who have helped in the major revision and rewriting of the text and in a broadening of the topics included. As a conse quence, the reader is assured of a thorough and thoroughly up-to-date coverage of current psychopharmacology that is both accurate and aimed at clinical utility. Having reached maturity, the third edition, while maintaining the lineaments of its earlier versions, is a considerably expanded and strengthened guide to treatment. Although now more encyclopedic in content, the new Practitioner' s Guide to Psy choactive Drugs retains the virtues of a clinical vade mecum that informed its predecessors and have eamed it a place by the patient's bedside for weIl over a decade. One may confidently anticipate its long and flourishing career in the years ahead. John C. Nemiah, M.D.
Editors and Affiliations
-
University of Arizona Health Sciences Center, Tucson, USA
Alan J. Gelenberg
-
The Better Homes Foundation, Newton Centre, USA
Ellen L. Bassuk
-
Harvard Medical School, Boston, USA
Ellen L. Bassuk
-
Schoonover Associates, Newton Centre, USA
Stephen C. Schoonover
